300639.SZ
凯普生物
SZSE · Healthcare · C 制造业 · CN
CNY 5.97
−3.40%Aug 31, 2026, 08:46 UTC
Hypro Biotechnology and its subsidiaries obtained a Chinese invention patent authorization for a sample tube fixing device and usage method in August 2026, which belongs to the in vitro diagnostic technology field.
Source:Jul 21, 2026, 10:22 UTC
Kaipu Bio's wholly-owned subsidiary Guangzhou Kaipu Medical Technology Co., Ltd. received a revised Medical Device Production License from the Guangdong Provincial Drug Administration, involving a change in production scope.
Source: